STAT+：Tango 在 Revolution Medicines 胰腺癌成果基础上推进
STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success
摘要
STAT+ 报道称，Tango 在 Revolution Medicines 胰腺癌成果的基础上继续推进。OpenAI 生命科学研究负责人 Joy Jiao 在 Scripps Research 生物技术创新峰会上表示，模型在化学和生物学上达到超人类水平只是时间问题，她认为这将在未来一两年内发生。
摘要由模型根据原文撰写，以原文为准。
正文 · 原文
Star Therapeutics’ fundraise, investors punish Moderna’s stock, and more biotech news
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla.
Joy Jiao, head of life sciences research at OpenAI, said during her fireside: “I think it’s really only a matter of time before the models become superhuman at chemistry and biology … I really do think that’s going to happen in the next year or two and that’s what I find very exciting.”
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Biotech Correspondent
Meghana Keshavan covers biotech and contributes to The Readout newsletter.
-
West Coast Biotech & Life Sciences Reporter
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27.
注意转载授权 · 阅读原文
来源：STAT News · statnews.com
引用原文
Meghana Keshavan and Jonathan Wosen. STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success[EB/OL]. (2026-10-23)[访问日期]. https://www.statnews.com/2026/10/23/tango-pancreatic-cancer-star-moderna-readout-newsletter/?utm_campaign=rss.